Why are some sickle cell disease patients protected from the disease? Learn about our biomedical research in the field.

Read how nature's medicine chest empowers our drug discovery chemists to advance biomedical research

How two years in a Novartis lab changed Johnny Castillo’s life.

Three years after discussing how to reuse an old scientific measuring device, Novartis scientists are now testing this idea as part of an innovative research project.

Over the next 15 years chronic disease like cancer and heart disease will become major killers in Sub-Saharan Africa. A new report from the Economist Intelligence Unit explains why.

Chronic diseases kill 38 million people per year worldwide; almost three-quarters of those deaths occur in low- and middle-income countries. It’s time to act.

Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.

In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.

Dr. Matchaba describes how his unique background can help guide the company’s access-to-medicine efforts.

Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.